List of Nereus Pharmaceuticals patents

Patents where

Current Assignee

Name

‌

Nereus Pharmaceuticals

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7026322 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds	Patent 7026322 was granted and assigned to Nereus Pharmaceuticals on April, 2006 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7026322	April 11, 2006
‌ US Patent 7276530 [3.2.0] Heterocyclic compounds and methods of using the same	Patent 7276530 was granted and assigned to Nereus Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7276530	October 2, 2007
‌ US Patent 8067616 Total synthesis of salinosporamide A and analogs thereof	Patent 8067616 was granted and assigned to Nereus Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	8067616	November 29, 2011
‌ US Patent 7824698 Lyophilized formulations of Salinosporamide A	Patent 7824698 was granted and assigned to Nereus Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7824698	November 2, 2010
‌ US Patent 8003802 Total synthesis of Salinosporamide A and analogs thereof	Patent 8003802 was granted and assigned to Nereus Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	8003802	August 23, 2011
‌ US Patent 7250438 Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams	Patent 7250438 was granted and assigned to Nereus Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7250438	July 31, 2007
‌ US Patent 6972289 Cell division inhibitor and a production method thereof	Patent 6972289 was granted and assigned to Nereus Pharmaceuticals on December, 2005 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	6972289	December 6, 2005
‌ US Patent 7572606 Biosyntheses of salinosporamide A and its analogs and related methods of making salinosporamide A and its analogs	Patent 7572606 was granted and assigned to Nereus Pharmaceuticals on August, 2009 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7572606	August 11, 2009
‌ US Patent 8168803 Methods of using [3.2.0] heterocyclic compounds and analogs thereof	Patent 8168803 was granted and assigned to Nereus Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	8168803	May 1, 2012
‌ US Patent 7342125 Method of treating inflammation with acanthoic acid derivatives	Patent 7342125 was granted and assigned to Nereus Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7342125	March 11, 2008
‌ US Patent 7378530 Anti-cancer and anti-microbial 5-membered heterocyclic compounds	Patent 7378530 was granted and assigned to Nereus Pharmaceuticals on May, 2008 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7378530	May 27, 2008
‌ US Patent 7579371 Methods of using [3.2.0] heterocyclic compounds and analogs thereof	Patent 7579371 was granted and assigned to Nereus Pharmaceuticals on August, 2009 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7579371	August 25, 2009
‌ US Patent 7550604 Pyrroloterpenes and use of the same as antimicrobial and anticancer agents	Patent 7550604 was granted and assigned to Nereus Pharmaceuticals on June, 2009 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7550604	June 23, 2009
‌ US Patent 8247552 Analogs of dehydrophenylahistins and their therapeutic use	Patent 8247552 was granted and assigned to Nereus Pharmaceuticals on August, 2012 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	8247552	August 21, 2012
‌ US Patent 7956058 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof	Patent 7956058 was granted and assigned to Nereus Pharmaceuticals on June, 2011 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7956058	June 7, 2011
‌ US Patent 7919497 Analogs of dehydrophenylahistins and their therapeutic use	Patent 7919497 was granted and assigned to Nereus Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7919497	April 5, 2011
‌ US Patent 7674903 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof	Patent 7674903 was granted and assigned to Nereus Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7674903	March 9, 2010
‌ US Patent 7935704 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof	Patent 7935704 was granted and assigned to Nereus Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7935704	May 3, 2011
‌ US Patent 7064201 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof	Patent 7064201 was granted and assigned to Nereus Pharmaceuticals on June, 2006 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7064201	June 20, 2006
‌ US Patent 7910616 Proteasome inhibitors	Patent 7910616 was granted and assigned to Nereus Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7910616	March 22, 2011
‌ US Patent 8227503 Proteasome inhibitors	Patent 8227503 was granted and assigned to Nereus Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	8227503	July 24, 2012
‌ US Patent 7842814 Total synthesis of salinosporamide A and analogs thereof	Patent 7842814 was granted and assigned to Nereus Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7842814	November 30, 2010
‌ US Patent 7732605 Synthesis of diketopiperazines	Patent 7732605 was granted and assigned to Nereus Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7732605	June 8, 2010
‌ US Patent 7112581 Macrocyclic lactams	Patent 7112581 was granted and assigned to Nereus Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7112581	September 26, 2006
‌ US Patent 7375129 Bis-indole pyrroles useful as antimicrobials agents	Patent 7375129 was granted and assigned to Nereus Pharmaceuticals on May, 2008 by the United States Patent and Trademark Office.	‌ Nereus Pharmaceuticals	United States Patent and Trademark Office	7375129	May 20, 2008

Results per page:

30 results

0 selected

30 results

0 selected